ZANTAC and other ranitidine products have been pulled from shelves after US retailer CVS suspended the sale of the heartburn drug to investigate links to cancer.
You Can See More: Zantac cancer risk: Heartburn drug suspended by CVS Pharmacy after cancer fears
The following article Zantac cancer risk: Heartburn drug suspended by CVS Pharmacy after cancer fears is courtesy of Daily Express :: Health Feed
ZANTAC and other ranitidine products have been pulled from shelves after US retailer CVS suspended the sale of the heartburn drug to investigate links to cancer.
ZANTAC and other ranitidine products have been pulled from shelves after US retailer CVS suspended the sale of the heartburn drug to investigate links to cancer.
Related Posts:
You Can See More: Bed bugs: How to stop an infestation in your home – key essentials to remember- You Can See More: Diabetes type 2 warning - do your feet look like this? The sore patches of skin
- You Can See More: Beverley Callard health: 'I will likely be medicated for life' star discusses her illness
- You Can See More: Skin cancer symptoms: The major warning signs that could indicate melanoma
- You Can See More: Best supplement for arthritis: The 28p natural remedy that could ease your joint pain
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.